Macular translocation for neovascular age-related macular degeneration
There is insufficient evidence from randomised controlled trials on the effectiveness of macular translocation, which is also not free of important risks. Furthermore, this technique is difficult to perform. Thus, macular translocation might not be considered for most patients with wet AMD given the treatment options already available.
No comments:
Post a Comment
Leave a Comment or Question: